Preferential hyperacuity perimeter in assessing responsiveness to ranibizumab therapy for exudative age-related macular degeneration

British Journal of Ophthalmology

Volumn 95, Issue 7, 2011, Pages 986-991

  Querques, Giuseppe ^a,b   Berboucha, Elya ^a   Leveziel, Nicolas ^a   Pece, Alfredo ^b   Souied, Eric H ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b Retina 3000 Foundation ONLUS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; EXUDATIVE MACULAR DEGENERATION; EYE EXAMINATION; EYE MOVEMENT; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MALE; OUTCOME ASSESSMENT; PERIMETER; PILOT STUDY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SCORING SYSTEM; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY;

AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUIPMENT DESIGN; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; PILOT PROJECTS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELD TESTS;

EID: 79959329906     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.190942     Document Type: Article

References (15)

1. Doris N, Hart PM, McCleland J, et al. Relation between macular morphology and visual function in patients with choroidal neovascularisation of age-related macular degeneration. Br J Ophthalmol 2001;85:184-8. (Pubitemid 32146758)
2. Hogg R, Stevenson MR, Winder J, et al. Macular lesion composition and location influence visual function in AMD. Br J Ophthalmol 2003;87:609-14. (Pubitemid 36535336)
3. Querques G, Bux AV, Prato R, et al. Correlation of visual function impairment and optical coherence tomography findings in patients with adult-onset foveomacular vitelliform macular dystrophy. Am J Ophthalmol 2008;146:135-42.
4. McClure M, Hart PM, Stevenson MR, et al. Correlations between visual function and performance of daily living tasks. Br J Ophthalmol 2000;84:244-50.
5. Mitchell J, Wolffsohn J, Woodcock A, et al. The MacDQoL individualized measure of the impact of macular degeneration on quality of life: reliability and responsiveness. Am J Ophthalmol 2008;146:447-54.
6. Moutray T, Alarbi M, Mahon G, et al. Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation. Br J Ophthalmol 2008;92:361-4. (Pubitemid 351363531)
7. Browning DJ, Glassman AR, Aiello LP, et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 2007;114:525-36.
8. Lalwani GA, Rosenfeld PJ, Fung AE, et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 2009;148:43-58.
9. Querques G, Azrya S, Martinelli D, et al. Ranibizumab for exudative age-related macular degeneration: 24-month outcomes from a single-centre institutional setting. Br J Ophthalmol 2010;94:292-6.
10. Alster Y, Bressler NM, Bressler SB, et al. Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study. Ophthalmology 2005;112:1758-65. (Pubitemid 41400012)
11. Goldstein M, Loewenstein A, Barak A, et al. Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of agerelated macular degeneration. Retina 2005;25:296-303. (Pubitemid 40517358)
12. Loewenstein A, Ferencz J, Lang Y, et al. Toward earlier detection of choroidal neovascularization secondary to age-related macular degeneration: multicenter evaluation of a preferential hyperacuity perimeter designed as a home device. Retina 2010;30:1058-64.
13. Trevino R. Recent progress in macular function self assessment. Ophthalmic Physiol Opt 2008;28:183-92. (Pubitemid 351569418)
14. Das R, Shi Y, Silvestri G, et al. Distortion maps from preferential hyperacuity perimetry are helpful in monitoring functional response to Lucentis therapy. Retina 2009;29:1013-18.
15. Bland JM, Altman DG. Statistics notes: calculating correlation coefficients with repeated observations: part 1-correlation within subjects. BMJ 1995;310:446.